Pharmacoadherence

A new term for a significant problem

Research output: Contribution to journalComment/debate

16 Citations (Scopus)

Abstract

We defined pharmacoadherence as the extent to which a patient follows a given therapeutic medication regimen as agreed on in partnership with a health care professional. Rates of pharmacoadherence among the general patient population are variable, with the World Health Organization estimating an average rate of 50%.1,7 Given the critical interplay between pharmacoadherent behaviors, health outcomes, and health care costs, it is important to have a clear understanding of what the term pharmacoadherence really means as well as reliable and valid assessment measures and effective interventions to target deficits in pharmacoadherence. Future research should continue to refine measures of assessment and intervention protocols to improve pharmacoadherence.

Original languageEnglish (US)
Pages (from-to)661-667
Number of pages7
JournalAmerican Journal of Health-System Pharmacy
Volume65
Issue number7
DOIs
StatePublished - Apr 1 2008

Fingerprint

Health Care Costs
Delivery of Health Care
Health
Population
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Health Policy

Cite this

Pharmacoadherence : A new term for a significant problem. / Chisholm-Burns, Marie; Spivey, Christina.

In: American Journal of Health-System Pharmacy, Vol. 65, No. 7, 01.04.2008, p. 661-667.

Research output: Contribution to journalComment/debate

@article{f0b570eb2328487b9c320a4bfbc66244,
title = "Pharmacoadherence: A new term for a significant problem",
abstract = "We defined pharmacoadherence as the extent to which a patient follows a given therapeutic medication regimen as agreed on in partnership with a health care professional. Rates of pharmacoadherence among the general patient population are variable, with the World Health Organization estimating an average rate of 50{\%}.1,7 Given the critical interplay between pharmacoadherent behaviors, health outcomes, and health care costs, it is important to have a clear understanding of what the term pharmacoadherence really means as well as reliable and valid assessment measures and effective interventions to target deficits in pharmacoadherence. Future research should continue to refine measures of assessment and intervention protocols to improve pharmacoadherence.",
author = "Marie Chisholm-Burns and Christina Spivey",
year = "2008",
month = "4",
day = "1",
doi = "10.2146/ajhp070372",
language = "English (US)",
volume = "65",
pages = "661--667",
journal = "American Journal of Health-System Pharmacy",
issn = "1079-2082",
publisher = "American Society of Health-Systems Pharmacy",
number = "7",

}

TY - JOUR

T1 - Pharmacoadherence

T2 - A new term for a significant problem

AU - Chisholm-Burns, Marie

AU - Spivey, Christina

PY - 2008/4/1

Y1 - 2008/4/1

N2 - We defined pharmacoadherence as the extent to which a patient follows a given therapeutic medication regimen as agreed on in partnership with a health care professional. Rates of pharmacoadherence among the general patient population are variable, with the World Health Organization estimating an average rate of 50%.1,7 Given the critical interplay between pharmacoadherent behaviors, health outcomes, and health care costs, it is important to have a clear understanding of what the term pharmacoadherence really means as well as reliable and valid assessment measures and effective interventions to target deficits in pharmacoadherence. Future research should continue to refine measures of assessment and intervention protocols to improve pharmacoadherence.

AB - We defined pharmacoadherence as the extent to which a patient follows a given therapeutic medication regimen as agreed on in partnership with a health care professional. Rates of pharmacoadherence among the general patient population are variable, with the World Health Organization estimating an average rate of 50%.1,7 Given the critical interplay between pharmacoadherent behaviors, health outcomes, and health care costs, it is important to have a clear understanding of what the term pharmacoadherence really means as well as reliable and valid assessment measures and effective interventions to target deficits in pharmacoadherence. Future research should continue to refine measures of assessment and intervention protocols to improve pharmacoadherence.

UR - http://www.scopus.com/inward/record.url?scp=41749123033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41749123033&partnerID=8YFLogxK

U2 - 10.2146/ajhp070372

DO - 10.2146/ajhp070372

M3 - Comment/debate

VL - 65

SP - 661

EP - 667

JO - American Journal of Health-System Pharmacy

JF - American Journal of Health-System Pharmacy

SN - 1079-2082

IS - 7

ER -